课题基金 / 基金详情

项目摘要

项目成果

RICHARD D SCHULICK的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 高层领导团队体现了UCCC的核心价值观,即合作,富有同情心, 模范的、包容的、学术的、有远见的和变革性的。领导班子努力打造充满活力的 和协作文化,以加强科学发现,利用研究界的优势, 促进跨学科协作,寻求创新和突破障碍,并取得关键的新成果 这些发现的目的是减轻科罗拉多州及其他地区癌症的负担和影响。高年级学生 领导团队着手进行战略规划、招聘、刺激新计划、方案和 成员支持,以及广泛的内部/外部协调和沟通。UCCC领导人作为一名 实施优先事项和实现目标的有凝聚力的团队,从合作机构(包括 安舒茨医学院,科罗拉多大学博尔德分校,科罗拉多州立大学,国立犹太人 卫生和各种临床附属机构),并征求集水区代表的意见。我们的特定 领导力、规划和评估的目标是: 目标1:促进科学发现及其翻译影响。我们促进招聘,将科学家聚集在一起 跨合作机构,通过试点基金提供激励,增强共享资源,并支持我们的 成员之间通过交流思想、建设基础设施和消除体制障碍。 目标2:不断调整各伙伴机构的UCCC活动,以实现降低癌症发病率的目标 并改善癌症患者的预后。高级领导团队通过有效地实现这一点 沟通、战略合作伙伴关系以及内部和外部顾问 评估和调整。 目标3:通过指定的领头羊、指标和 问责制。领导团队负责战略计划的实施,制定衡量标准 并要求自己和其他冠军对实现目标负责。此外,该团队还授予 当需要对计划进行调整时,包括重新确定目标的优先顺序或利用以前未预见到的 机遇。 领导团队促进和支持协作的、跨学科的研究,以加速科学研究 发现、临床护理、预防、教育以及社区外展和参与。归根结底, UCCC的流程和领导者到位,创建了一个不断发展的强大、健壮的癌症中心 并在消除癌症方面取得重大进展。
英文摘要
ABSTRACT The senior leadership team embodies UCCC core values, which are to be collaborative, compassionate, exemplary, inclusive, scholarly, visionary, and transformative. The leadership team strives to create an energetic and collaborative culture to enhance scientific discovery that leverages the strengths of research community, fosters collaborations across disciplines, seeks to innovate and break barriers, and makes critical new discoveries, with the goal of reducing the burden and impact of cancer in Colorado and beyond. The senior leadership team embarks on strategic planning, recruitment, stimulus for new initiatives, programmatic and member support, and extensive internal/external coordination and communication. UCCC leaders work as a cohesive team to implement priorities and achieve goals, pulling in members from partner institutions (including the Anschutz Medical Campus, the University of Colorado at Boulder, Colorado State University, National Jewish Health, and various clinical affiliates) and seeking input from representatives of the catchment area. Our specific aims for leadership, planning, and evaluation are: Aim 1: Foster scientific discovery and its translational impact. We facilitate recruitment, bring scientists together across partner institutions, offer incentives through pilot funds, enhance shared resources, and support our members by exchanging ideas, building infrastructure, and removing institutional barriers. Aim 2: Continuously align UCCC activities across the partner institutions with the goal to reduce cancer incidence and improve outcomes for cancer patients. The senior leadership team achieves this through effective communication, strategic partnerships, and internal and external advisors in a continuous, iterative process of evaluation and realignment. Aim 3: Orchestrate strategic planning and its implementation through designated champions, metrics, and accountability. The leadership team is responsible for the implementation of the strategic plan, setting metrics and holding themselves and fellow champions accountable for accomplishing goals. In addition, the team confers when adjustments to the plan are required, including re-prioritizing goals or leveraging previously unforeseen opportunities. The leadership team promotes and supports collaborative, transdisciplinary research that accelerates scientific discovery, clinical care, prevention, education, and community outreach and engagement. Ultimately, the process and leaders the UCCC has in place, create a strong, robust cancer center that is continually evolving and making significant strides toward the elimination of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University of Colorado Cancer Center Support Grant - CTRAC Supplement Yr 02
  • 批准号:
    10439981
  • 项目类别:
  • 资助金额:
    $8.25万
  • 财政年份:
    2021
  • 负责人:
    RICHARD D SCHULICK
  • 依托单位:
University of Colorado Cancer Center Support Grant
  • 批准号:
    10371494
  • 项目类别:
  • 资助金额:
    $11.5万
  • 财政年份:
    2021
  • 负责人:
    RICHARD D SCHULICK
  • 依托单位:
Colorado's Partnership to Implement Evidence-Based Interventions to Reduce the Cancer Burden
  • 批准号:
    10409393
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2021
  • 负责人:
    RICHARD D SCHULICK
  • 依托单位:
Interferon Signaling and the Differential Malignancy Spectrum of Down Syndrome
  • 批准号:
    9933418
  • 项目类别:
  • 资助金额:
    $46.16万
  • 财政年份:
    2019
  • 负责人:
    RICHARD D SCHULICK
  • 依托单位:
海外基金